Vinva Investment Management Ltd Has $12.26 Million Position in Morgan Stanley $MS

Vinva Investment Management Ltd grew its holdings in shares of Morgan Stanley (NYSE:MS) by 5.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 76,055 shares of the financial services provider’s stock after buying an additional 4,124 shares during the quarter. Vinva Investment Management Ltd’s holdings in Morgan Stanley were worth $12,257,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Greykasell Wealth Strategies Inc. increased its position in shares of Morgan Stanley by 65.2% in the third quarter. Greykasell Wealth Strategies Inc. now owns 185 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 73 shares during the last quarter. WFA of San Diego LLC acquired a new position in Morgan Stanley during the second quarter valued at approximately $28,000. Family Legacy Financial Solutions LLC boosted its position in Morgan Stanley by 91.9% during the third quarter. Family Legacy Financial Solutions LLC now owns 213 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 102 shares during the last quarter. Compass Financial Services Inc bought a new position in Morgan Stanley in the second quarter valued at approximately $32,000. Finally, Ameriflex Group Inc. grew its stake in Morgan Stanley by 220.0% in the third quarter. Ameriflex Group Inc. now owns 240 shares of the financial services provider’s stock valued at $38,000 after purchasing an additional 165 shares in the last quarter. 84.19% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Morgan Stanley

Here are the key news stories impacting Morgan Stanley this week:

• Positive Sentiment: Morgan Stanley filed an updated S‑1 / SEC amendment advancing its planned spot Bitcoin ETF (naming Coinbase custody and BNY Mellon roles). That materially increases the firm’s potential fee pool (trading, custody, securities lending) if approved — a strategic growth lever beyond traditional banking. Morgan Stanley Files Updated SEC Amendment for Spot Bitcoin ETF Launch
• Positive Sentiment: Morgan Stanley provided financing (initial $500M, expandable to $1B) to Core Scientific for data center/AI infrastructure, demonstrating growth in corporate lending and structured finance opportunities tied to AI/crypto infrastructure. That can add fee and interest income if credit performance holds. Core Scientific secures up to $1B credit from Morgan Stanley for data centers
• Neutral Sentiment: Public commentary from Morgan Stanley events (tech/AI conferences) keeps the firm visible as an advisor/market‑maker in tech and AI financing; useful for long‑term franchise positioning but not an immediate earnings surprise. Morgan Stanley’s top tech banker: It’s ‘wartime, not peacetime’ for software
• Negative Sentiment: Morgan Stanley announced cuts of roughly 2,500 roles (~3% of workforce) across divisions. Markets often react negatively to broad layoffs because they signal restructuring risk, potential disruption to revenue growth and near‑term execution uncertainty even if they imply future cost savings. Morgan Stanley Sheds 2,500 Employees in Companywide Layoffs
• Negative Sentiment: Investor flow appears to favor trimming MS exposure amid the headlines; analysts and market commentators are re‑assessing near‑term margins and execution risk despite record revenues in 2025 — producing downward pressure on the share price today. Morgan Stanley Cuts 3% Workforce Despite Record Revenues in 2025

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on MS shares. Jefferies Financial Group upped their price objective on Morgan Stanley from $186.00 to $212.00 and gave the stock a “buy” rating in a research note on Tuesday, January 6th. Wolfe Research reissued an “outperform” rating and issued a $211.00 target price on shares of Morgan Stanley in a research note on Wednesday, January 7th. Barclays boosted their target price on shares of Morgan Stanley from $183.00 to $219.00 and gave the stock an “overweight” rating in a report on Monday, January 5th. JPMorgan Chase & Co. upped their price target on shares of Morgan Stanley from $157.00 to $162.00 and gave the stock a “neutral” rating in a research report on Thursday, January 8th. Finally, Wall Street Zen upgraded shares of Morgan Stanley from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $185.93.

Insiders Place Their Bets

In other Morgan Stanley news, CFO Sharon Yeshaya sold 15,838 shares of the firm’s stock in a transaction that occurred on Tuesday, January 20th. The shares were sold at an average price of $185.77, for a total transaction of $2,942,225.26. Following the completion of the sale, the chief financial officer directly owned 135,304 shares in the company, valued at $25,135,424.08. This trade represents a 10.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Daniel A. Simkowitz sold 32,968 shares of the business’s stock in a transaction that occurred on Friday, January 30th. The stock was sold at an average price of $182.61, for a total value of $6,020,286.48. Following the sale, the insider owned 357,342 shares of the company’s stock, valued at approximately $65,254,222.62. This represents a 8.45% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 129,191 shares of company stock worth $23,736,506 in the last 90 days. Corporate insiders own 0.19% of the company’s stock.

Morgan Stanley Trading Down 1.5%

Shares of Morgan Stanley stock opened at $160.15 on Friday. The business has a fifty day simple moving average of $178.20 and a two-hundred day simple moving average of $167.85. Morgan Stanley has a 1 year low of $94.33 and a 1 year high of $192.68. The company has a market capitalization of $254.30 billion, a price-to-earnings ratio of 15.69, a P/E/G ratio of 1.29 and a beta of 1.20. The company has a debt-to-equity ratio of 3.39, a current ratio of 0.81 and a quick ratio of 0.81.

Morgan Stanley (NYSE:MS) last released its quarterly earnings data on Thursday, January 15th. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.28 by $0.40. The firm had revenue of $17.90 billion for the quarter, compared to the consensus estimate of $17.69 billion. Morgan Stanley had a net margin of 14.09% and a return on equity of 16.78%. The company’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the company earned $2.22 earnings per share. Research analysts forecast that Morgan Stanley will post 8.56 EPS for the current year.

Morgan Stanley Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Friday, January 30th were issued a dividend of $1.00 per share. The ex-dividend date of this dividend was Friday, January 30th. This represents a $4.00 annualized dividend and a dividend yield of 2.5%. Morgan Stanley’s payout ratio is presently 39.18%.

Morgan Stanley Profile

Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.

The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.